Finance

Beta
Lists
MNKD:NASDAQ
MannKind Corp
$3.77
+3.57%
(+0.13) 1D
$3.75
-0.53% (-0.020)
After hours
Closed: May 29, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MNKD...
Open
$3.66
High
$3.94
Low
$3.51
Mkt. cap
1.16B
Avg. vol.
5.83M
Volume
20.39M
52-wk high
$6.51
52-wk low
$2.23
EPS
-$0.08
Beta
1.04
Shares outstanding
308.95M
No. of employees
592
Open
$3.66
High
$3.94
Low
$3.51
Mkt. cap
1.16B
Avg. vol.
5.83M
Volume
20.39M
52-wk high
$6.51
52-wk low
$2.23
EPS
-$0.08
Beta
1.04
Shares outstanding
308.95M
No. of employees
592
News stories
From sources across the web
Profile
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991. MannKind Corporation was named after its founder, Alfred E. Mann. Wikipedia
About MannKind Corp
CEOMichael Castagna
Employees592
FoundedFeb 1991
HeadquartersDanbury, Connecticut, United States
SectorBiotechnology
Websitemannkindcorp.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
76.53M
82.13M
111.96M
90.17M
Cost of goods sold
20.57M
20.20M
29.67M
17.47M
Cost of revenue
20.57M
20.20M
29.67M
17.47M
Research and development expenses
13.68M
14.06M
27.59M
17.23M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
31.62M
29.09M
58.41M
54.08M
Operating expense
45.30M
43.15M
89.97M
75.68M
Total operating expenses
65.86M
63.35M
119.64M
93.16M
Operating income
10.66M
18.78M
-7.69M
-2.98M
Other non operating income
-
-
-2.04M
-
EBT including unusual items
940.00K
7.78M
-20.93M
-16.37M
EBT excluding unusual items
940.00K
14.19M
-21.96M
-12.67M
Income tax expense
272.00K
-204.00K
-4.98M
253.00K
Effective tax rate
28.94%
-2.62%
23.81%
-1.55%
Other operating expenses
-
-
-
-
Net income
668.00K
7.98M
-15.95M
-16.62M
Net profit margin
0.87%
9.72%
-14.24%
-18.43%
Earnings per share
0.05
0.07
0.01
-0.02
Interest and investment income
1.83M
2.63M
1.64M
1.43M
Interest expense
-6.19M
-7.33M
-13.87M
-12.43M
Net interest expenses
-4.36M
-4.71M
-12.24M
-11.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
12.75M
20.84M
-1.66M
3.40M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer